With as many as 13,000 patients possibly exposed to fungal meningitis from tainted spinal steroid injections traced to a New England compounding pharmacy, the regulation of compounding pharmacies is once again heating up.
The Alabama Department of Public Health (ADPH) released a list of 44 health care facilities in Alabama that received products from the compounding pharmacy, and nineteen Alabama residents have received contaminated steroid products from procedures performed in Tennessee and Florida. Although Dr. Don Williamson, State Health Officer, emphasized that the products shipped to Alabama facilities have no known association with the meningitis, nor have they been proven to be contaminated, both physician and patient alike have examined their use of compounded medications and whether or not they should be brought under greater regulatory scrutiny.
To read more about this topic, please see full article below
No representation is made that the quality of services to be performed is greater
than the quality of legal services performed by other lawyers.